Linden Thomas Advisory Services’s Halozyme HALO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.79M	Sell	27,641 -7,162	-21%	-$505K	0.17%	213
2025 Q4	$2.34M	Sell	34,803 -441	-1%	-$29.7K	0.24%	122
2025 Q3	$2.58M	Buy	35,244 +9	+0%	+$598	0.26%	111
2025 Q2	$1.83M	Sell	35,235 -646	-2%	-$36.8K	0.2%	161
2025 Q1	$2.29M	Buy	35,881 +890	+3%	+$51.7K	0.3%	102
2024 Q4	$1.67M	Sell	34,991 -349	-1%	-$17.9K	0.21%	171
2024 Q3	$2.02M	Buy	35,340 +12	+0%	+$688	0.28%	119
2024 Q2	$1.85M	Sell	35,328 -7,169	-17%	-$314K	0.29%	108
2024 Q1	$1.73M	Buy	42,497 +40	+0.1%	+$1.5K	0.28%	124
2023 Q4	$1.57M	Buy	42,457 +7	+0%	+$264	0.29%	127
2023 Q3	$1.62M	Buy	42,450 +5,126	+14%	+$210K	0.36%	79
2023 Q2	$1.35M	Buy	37,324 +181	+0.5%	+$6.18K	0.3%	129
2023 Q1	$1.42M	Buy	37,143 +894	+2%	+$41.9K	0.35%	108
2022 Q4	$2.06M	Buy	+36,249	New	+$1.86M	0.58%	29